Follistatin-like 3 across gestation in preeclampsia and uncomplicated pregnancies among lean and obese women

Reproductive Sciences

Volumn 22, Issue 4, 2015, Pages 402-409

  Founds, Sandra A ^a,b   Ren, Dianxu ^a   Roberts, James M ^b,c,d   Jeyabalan, Arun ^b,c   Powers, Robert W ^b,c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

adiposity; FSTL 3; FSTL3; obesity; preeclampsia

Indexed keywords

FOLLISTATIN; FOLLISTATIN LIKE 3; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; FOLLISTATIN RELATED PROTEIN;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HUMAN; LEAN BODY WEIGHT; MATERNAL PLASMA; OBESITY; PREECLAMPSIA; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; YOUNG ADULT; BLOOD; BLOOD PRESSURE; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; MULTIVARIATE ANALYSIS; ODDS RATIO; PATHOPHYSIOLOGY; PRE-ECLAMPSIA; PREGNANCY; RISK FACTOR; STATISTICAL MODEL; UPREGULATION;

ADIPOSITY; ADULT; BIOMARKERS; BLOOD PRESSURE; BODY MASS INDEX; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; FOLLISTATIN-RELATED PROTEINS; GESTATIONAL AGE; HUMANS; LOGISTIC MODELS; MULTIVARIATE ANALYSIS; OBESITY; ODDS RATIO; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTERS; RISK FACTORS; UP-REGULATION; YOUNG ADULT;

EID: 84927601604     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719114529372     Document Type: Article

References (47)

1. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol. 2002 ; 99 (1). 159-167
2. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005 ; 365 (9461). 785-799
3. World Health Organization. Maternal and perinatal health. http://www.who.int/reproductivehealth/topics/maternal-perinatal/epidemiology/en/index.html. Accessed March 10, 2013.
4. Founds S, Conley YP, Lyons-Weiler JF, Jeyabalan A, Hogge WA, Conrad KP. Global gene expression in first trimester placentas of women destined to develop preeclampsia. Placenta. 2009 ; 30 (1). 15-24
5. Founds SA, Terhorst LA, Conrad KP, Hogge WA, Jeyabalan A, Conley YP. Gene expression of eight candidates in first trimester preeclampsia placenta. Biol Res Nurs. 2011 ; 13 (2). 134-139
6. Tortoriello DV, Sidis Y, Holtzman DA, Holmes WE, Schneyer AL. Human follistatin-related protein: a structural homologue of follistatin with nuclear localization. Endocrinology. 2001 ; 142 (8). 3426-3434
7. Schneyer A, Sidis Y, Xia Y, et al. Differential actions of follistatin and follistatin-like 3. Molec Cell Endocr. 2004 ; 225 (1-2). 25-28
8. Maguer Satta V, Rimokh R. FLRG, member of the follistatin family, a new player in hematopoiesis. Mol Cell Endocrinol. 2004 ; 225 (1-2). 109-118
9. Hill JJ, Davies MV, Pearson AA, et al. The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum. J Biol Chem. 2002 ; 277 (43). 40735-40741
10. Sidis Y, Tortoriello DV, Holmes WE, Pan Y, Keutmann HT, Schneyer AL. Follistatin-related protein and follistatin differentially neutralize endogenous vs. exogenous activin. Endocrinology. 2002 ; 143 (5). 1613-1624
11. Guzeloglu-Kayisli O, Kayisli UA, Taylor HS. The role of growth factors and cytokines during implantation: endocrine and paracrine interactions. Semin Reprod Med. 2009 ; 27 (1). 62-79
12. Caniggia I, Winter J, Lye SJ, Post M. Oxygen and placental development during the first trimester: implications for the pathophysiology of pre-eclampsia. Placenta. 2000 ; 21: S25-S30
13. Brown ML, Bonomi L, Ungerleider N, et al. Follistatin and follistatin like-3 differentially regulate adiposity and glucose homeostasis. Obesity. 2011 ; 19 (10). 1940-1949
14. Allen DL, Cleary AS, Speaker KJ, et al. Myostatin, activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice. Am J Physiol Endocrinol Metab. 2008 ; 294 (5). E918-E927
15. Mukherjee A, Sidis Y, Mahan A, et al. FSTL3 deletion reveals roles for TGF-beta family ligands in glucose and fat homeostasis in adults. Proc Natl Acad Sci U S A. 2007 ; 104 (4). 1348-1353
16. Ciarmela P, Florio P, Toti P, et al. Human placenta and fetal membranes express follistatin-related gene mRNA and protein. J Endocrinol Invest. 2003 ; 26 (7). 641-645
17. Khong T, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol. 1986 ; 93 (10). 1049-1059
18. Meekins J, Pijnenborg R, Hanssens M, McFadyen IR, van Asshe A. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol. 1994 ; 101 (8). 669-674
19. Thadhani R, Powe CE, Tjoa ML, Khankin E, Ye J, Ecker J, Schneyer A, Karumanchi SA. First trimester follistatin-like-3 levels in pregnancies complicated by subsequent gestational diabetes mellitus. Diabetes Care. 2010 ; 33 (3). 664-669
20. Miron P, Lambert J, Marcil A, Cowans NJ, Stamatopoulou A, Spencer K. Maternal plasma levels of follistatin-related gene protein in the first trimester of pregnancies with Down syndrome. Prenat Diagn. 2010 ; 30 (3). 224-228
21. Pryor-Koishi K, Nishizawa H, Kato T, et al. Overproduction of the follistatin-related gene protein in the placenta and maternal serum of women with pre-eclampsia. Br J Obstet Gynaecol. 2007 ; 114 (9). 1128-1137
22. Guo J, Tian T, Lu D, Xia G, Wang H, Dong M. Alterations of maternal serum and placental follistatin-like 3 and myostatin in pre-eclampsia. J Obstet Gynaecol Res. 2012 ; 38 (7). 988-996
23. Yamamoto S, Douchi T, Yoshimitsu N, Nakae M, Nagata Y. Waist to hip circumference ratio as a significant predictor of preeclampsia, irrespective of overall adiposity. J Obstet Gynaecol Res. 2001 ; 27 (1). 27-31
24. Founds SA, Powers RW, Patrick TE, et al. A comparison of circulating TNF-alpha in obese and lean women with and without preeclampsia. Hypertens Pregnancy. 2008 ; 27 (1). 39-48
25. Roberts JM, Pearson G, Cutler J, Lindheimer M. Summary of the NHLBI working group on research on hypertension during pregnancy. Hypertension. 2003 ; 41 (3). 437-445
26. Lukaski HC, Siders WA, Nielsen EJ, Hall CB. Total body water in pregnancy: assessment by using bioelectrical impedance. Am J Clin Nutr. 1994 ; 59 (3). 578-585
27. van Raaij JM, Peek ME, Vermaat-Miedema SH, Schonk CM, Hautvast JG. New equations for estimating body fat mass in pregnancy from body density or total body water. Am J Clin Nutr. 1988 ; 48 (1). 24-29
28. McCarthy EA, Strauss BJ, Walker SP, Permezel M. Determination of maternal body composition in pregnancy and its relevance to perinatal outcomes. Obstet Gynecol Surv. 2004 ; 59 (10). 731-742
29. Bergman RN, Stefanovski D, Buchanan TA, et al. A better index of body adiposity. Obesity (Silver Spring). 2011 ; 19 (5). 1083-1089
30. Hayette S, Gadoux M, Martel S, et al. FLRG (follistatin-related gene), a new target of chromosomal rearrangement in malignant blood disorders. Oncogene. 1998 ; 16 (22). 2949-2954
31. Biron-Shental T, Schaiff WT, Rimon E, Shim TL, Nelson DM, Sadovsky Y. Hypoxia enhances the expression of follistatin-like 3 in term human trophoblasts. Placenta. 2008 ; 29 (1). 51-57
32. Roberts J, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol. 1989 ; 161 (5). 1200-1204
33. Roberts JM, Hubel CA. Oxidative stress in preeclampsia. Am J Obstet Gynecol. 2004 ; 190 (5). 1177-1178
34. Myatt L, Clifton RG, Roberts JM, et al. First-trimester prediction of preeclampsia in nulliparous women at low risk. Obstet Gynecol. 2012 ; 119 (6). 1234-1242
35. Eskenazi B, Fenster L, Sidney S. A multivariate analysis of risk factors for preeclampsia. JAMA. 1991 ; 266 (2). 237-241
36. Kaaja R, Laivuori H, Laakso M, Tikkanen MJ, Ylikorkala O. Evidence of a state of increased insulin resistance in preeclampsia. Metabolism. 1999 ; 48 (7). 892-896
37. Bartholin L, Maguer-Satta V, Hayette S, et al. Transcription activation of FLRG and follistatin by activin A, through Smad proteins, participates in a negative feedback loop to modulate activin A function. Oncogene. 2002 ; 21 (14). 2227-2235
38. Ogawa K, Funaba M, Chen Y, Tsujimoto M. Activin A functions as a Th2 cytokine in the promotion of the alternative activation of macrophages. J Immunol. 2006 ; 177 (10). 6787-6794
39. Hu D, Tian T, Guo J, Wang H, Chen D, Dong M. Decreased maternal and placental concentrations of follistatin-like 3 in gestational diabetes. Clin Chim Acta. 2012 ; 413 (5-6). 533-536
40. Samuel VT, Petersen KF, Shulman GI. Lipid-induced insulin resistance: unravelling the mechanism. Lancet. 2010 ; 375 (9733). 2267-2277
41. Catalano PM. Obesity, insulin resistance, and pregnancy outcome. Reproduction. 2010 ; 140 (3). 365-371
42. Butte NF. Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. Am J Clin Nutr. 2000 ; 71: 1256S-1261S
43. Catalano PM, Roman-Drago NM, Amini SB, Sims EA. Longitudinal changes in body composition and energy balance in lean women with normal and abnormal glucose tolerance during pregnancy. Am J Obstet Gynecol. 1998 ; 179 (1). 156-165
44. Homko CJ, Sivan E, Reece EA, Boden G. Fuel metabolism during pregnancy. Semin Reprod Endocrinol. 1999 ; 17 (2). 119-125
45. Oshima Y, Ouchi N, Shimano M, et al. Activin A and follistatin-like 3 determine the susceptibility of heart to ischemic injury. Circulation. 2009 ; 120 (16). 1606-1615
46. Levario-Carrillo M, Avitia M, Tufiño-Olivares E, Trevizo E, Corral-Terrazas M, Reza-López S. Body composition of patients with hypertensive complications during pregnancy. Hypertens Pregnancy. 2006 ; 25 (3). 259-269
47. da Silva EG, Carvalhaes MA, Hirakawa HS, da Silva EG, Peraçoli JC. Bioimpedance in pregnant women with preeclampsia. Hypertens Pregnancy. 2010 ; 29 (4). 357-365